NLRC5 potentiates anti-tumor CD8+ T cells responses by activating interferon-β in endometrial cancer

MLA

Jing Zhang, et al. “NLRC5 Potentiates Anti-Tumor CD8+ T Cells Responses by Activating Interferon-β in Endometrial Cancer.” Translational Oncology, vol. 36, no. 101742-, Oct. 2023. EBSCOhost, https://doi.org/10.1016/j.tranon.2023.101742.

APA

Jing Zhang, Bao Guo, Jia-Hua Chen, Xiao-Jing Liu, Jun-Hui Zhang, Hai-Qing Zhu, Wen-Yan Wang, Zhen-Hai Tang, Bing Wei, Yun-Xia Cao, & Lei Zhan. (2023). NLRC5 potentiates anti-tumor CD8+ T cells responses by activating interferon-β in endometrial cancer. Translational Oncology, 36(101742-). https://doi.org/10.1016/j.tranon.2023.101742

Chicago

Jing Zhang, Bao Guo, Jia-Hua Chen, Xiao-Jing Liu, Jun-Hui Zhang, Hai-Qing Zhu, Wen-Yan Wang, et al. 2023. “NLRC5 Potentiates Anti-Tumor CD8+ T Cells Responses by Activating Interferon-β in Endometrial Cancer.” Translational Oncology 36 (101742-). doi:10.1016/j.tranon.2023.101742.